FIBROGEN, INC.

FGEN

Delayed - 01/26 04:00:00 pm
48.99USD	-1.21%

03/03/21	FY 2020 Earnings Release (Projected)
05/13/21	Q1 2021 Earnings Release (Projected)
08/09/21	Interim 2021 Earnings Release (Projected)
11/11/21	Q3 2021 Earnings Release (Projected)

12/06/20 \| 10:00am	American Society of Hematology Meeting - ePoster #1671
12/05/20 \| 10:00am	American Society of Hematology Meeting - ePoster #1277
12/05/20 \| 10:00am	American Society of Hematology Meeting - ePoster #766
12/05/20 \| 10:00am	American Society of Hematology Meeting - ePoster #761

01/27/21	LONZA GROUP LTD : FY 2020 Earnings Release
01/27/21 \| 08:30am	LONZA GROUP LTD : FY 2020 Earnings Call
01/27/21	GALAPAGOS NV : Degroof Petercam Healthcare Conference
01/31/21	TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference

01/21/21 \| 10:30pm	BIOCON LIMITED : Q3 2021 Earnings Call
01/21/21	SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
01/21/21	BIOCON LIMITED : Q3 2021 Earnings Release
01/20/21 \| 01:00pm	IOVANCE BIOTHERAPEUTICS, INC. : B. Riley Oncology Investor Conference

Previous year

Next Year

Annual results		2015	2016	2017	2018	2019	2020 (e)
Sales M $	Released Forecast Spread	181 191 -5,4%	180 169 6,4%	126 133 -5,5%	213 177 20%	257 285 -9,8%	217
Operating income (EBITDA) M $	Released Forecast Spread	-71,9 -39,0 -85%	-47,6 -39,7 -20%	-117 -96,2 -21%	-80,1 -82,6 2,9%	-78,2 -6,18 -1 165%	-130
Operating profit (EBIT) M $	Released Forecast Spread	-77,6 -56,9 -36%	-53,7 -52,3 -2,6%	-123 -116 -5,3%	-86,7 -113 23%	-89,3 -36,7 -143%	-161
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-85,5 -57,2 -50%	-61,8 -60,7 -1,8%	-126 -129 2,0%	-86,1 -109 21%	-76,6 -29,1 -163%	-160
Net income M $	Released Forecast Spread	-85,8 -55,7 -54%	-61,7 -60,6 -1,8%	-126 -129 1,9%	-86,4 -110 21%	-77,0 -29,5 -161%	-158
EPS $	Released Forecast Spread	-1,42 -1,16 -23%	-0,98 -0,95 -2,7%	-1,73 -1,78 2,9%	-1,03 -1,31 21%	-0,89 -0,34 -162%	-1,69
Announcement Date		02/29/2016	03/01/2017	02/27/2018	02/27/2019	03/02/2020

Previous period

Next period

Quarterly results		2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4 (e)	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)
Sales M $	Released Forecast Spread	44,0 27,7 58%	29,0 36,5 -20%	108 72,1 50%	23,9 20,4 17%	192 29,0 560%	33,2 31,6 5,0%	7,97 40,3 -80%	24,4 72,6 -66%	42,9 48,3 -11%	44,0 61,5 -28%	106	117	104	140	89,3
Operating income (EBITDA) M $	Released Forecast Spread									-79,6 55,3 -244%	37,9 -4,87 878%	-3,02
Operating profit (EBIT) M $	Released Forecast Spread	-23,2 -49,4 53%	-42,8 -33,5 -28%	19,9 -11,4 274%	-48,8 -57,6 15%	113 -42,6 365%	-52,9 -52,6 -0,48%	-100 -51,8 -94%	-81,1 -35,9 -126%	-85,1 -59,2 -44%	32,3 -69,0 147%	-22,1	-17,4	-47,2	-3,82	-58,4
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-23,3 -50,5 54%	-42,4 -25,3 -68%	21,0 -2,14 1 080%	-45,4 -56,5 20%	116 -40,1 390%	-49,4 -47,0 -5,0%	-98,1 -50,5 -94%	-78,5 -32,4 -142%	-85,1 -70,2 -21%	33,2 -75,0 144%	-21,3	-21,7	-41,3	11,0	-72,3
Net income M $	Released Forecast Spread	-23,4 -50,5 54%	-42,6 -25,3 -69%	21,0 -2,23 1 038%	-45,4 -56,5 20%	116 -40,1 389%	-49,4 -47,1 -4,9%	-98,1 -50,6 -94%	-78,3 -32,4 -142%	-85,3 -50,2 -70%	33,0 -65,8 150%	-19,5	-21,8	-41,4	10,9	-72,4
EPS $	Released Forecast Spread	-0,28 -0,61 54%	-0,50 -0,30 -67%	0,23 -0,03 1 020%	-0,53 -0,66 20%	1,26 -0,46 372%	-0,57 -0,54 -5,6%	-1,12 -0,58 -94%	-0,89 -0,28 -215%	-0,95 -0,56 -69%	0,35 -0,73 148%	-0,21	-0,24	-0,44	0,11	-0,77
Announcement Date		08/07/2018	11/08/2018	02/27/2019	05/09/2019	08/08/2019	11/11/2019	03/02/2020	05/07/2020	08/06/2020	11/05/2020